Please login to the form below

Not currently logged in
Email:
Password:

Lucid launches rare and specialist disease agency

Vivid MedComms will be headed by Alison Cantle

VividUK-based Lucid Group, has opened Vivid Medcomms, a new agency that will focus on rare diseases and be based in Buckinghamshire, UK.

Vivid will be headed up by managing director Alison Cantle, who was previously a business unit director at Lucid and has over 20 years’ medical communications experience.

She said: “Our business in rare diseases has increased threefold over the last year and making the decision to create a new stand-alone company focused on this area is an obvious choice.”

According to analysts at Evaluate Pharma sales of orphan drugs are set to account for 20% of all prescription drug sales by 2020.

The move mirrors an “industry-wide shift” towards focusing on rare and specialist disease, with revenues from orphan drugs ‘outpacing’ sales of mainstream drugs for the last decade, explained Lucid.

Cantle added: “We have developed a dedicated and talented team of account handlers and medical writers brimming with a specific skills and experience related to developing excellent comms programmes in rare diseases.

“The team are excited by the challenge and looking forward to transforming the lives of both clients and teams in this space.”

Article by
Gemma Jones

13th November 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change
Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly....
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the...
Could femtech be the answer to the gender health gap?
Here, we discuss the phenomenon of femtech, an industry that puts women’s experiences of lifestyle and health front and centre. We highlight some of the major players in the industry,...